l 158809 has been researched along with bradykinin in 2 studies
| Studies (l 158809) | Trials (l 158809) | Recent Studies (post-2010) (l 158809) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
|---|---|---|---|---|---|
| 137 | 0 | 7 | 14,195 | 355 | 1,520 |
| Protein | Taxonomy | l 158809 (IC50) | bradykinin (IC50) |
|---|---|---|---|
| B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fogo, A; Ichikawa, I; Kon, V | 1 |
| Carretero, OA; Liu, YH; Nass, O; Peterson, E; Sabbah, HN; Sharov, VG; Yang, XP | 1 |
2 other study(ies) available for l 158809 and bradykinin
| Article | Year |
|---|---|
Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition.
Topics: Angiotensin Receptor Antagonists; Animals; Arterioles; Bradykinin; Bradykinin Receptor Antagonists; Enalapril; Furosemide; Imidazoles; Male; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Vasodilation; Water Deprivation | 1993 |
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Cardiovascular System; Disease Models, Animal; Drug Interactions; Heart Failure; Imidazoles; Kinins; Male; Models, Cardiovascular; Myocardial Infarction; Myocardium; Pyridines; Ramipril; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Tetrazoles | 1997 |